Not stock tips. Not hot takes. Structural themes backed by generational forces — presented without the jargon, with a healthy dose of scepticism, and a clear investment angle.
Ozempic was just the opening act. Peptides are reshaping medicine — from metabolic disease to muscle repair to cognitive health. The longevity trade has a new face, and it's very small.
→Markets have priced the disruption half of AI. They haven't priced the scarcity half. The more AI automates the cognitive economy, the more valuable physical builders, human credentials, and irreplaceable infrastructure become.
→Every industrial revolution has given us more leisure hours. AI will accelerate that dramatically. The question isn't whether people will have more free time — it's who will profit when they spend it. Golf tee times are already fully booked.
→AI software is the most visible and most volatile layer of this trade. Three layers beneath it — chips, data centres, rare metals, and quantum computing — the structural case is harder to argue with.
→Two structural inefficiencies in the credit market — forced selling on downgrade, and mis-priced callable bonds at the top of high yield. You just need to know where to look.
→